Dynemo Biosystems is a service provided by Mount Sinai Hospital. The core technology was developed by Dr. Jeff Wrana, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Mary Janigan Research Chair in Molecular Cancer Therapeutics and Ian Taylor, a PhD student under Dr. Wrana's supervision.
The Samuel Lunenfeld Research Institute of Mount Sinai Hospital, a University of Toronto affiliated research centre established in 1985, is one of the world’s premier centres in biomedical research. Thirty-four principal investigators lead research in diabetes, cancer biology, epidemiology, stem cell research, women’s and infants’ health, neurobiology and systems biology. For more information on the Samuel Lunenfeld Research Institute, please visit www.lunenfeld.ca
The Samuel Lunenfeld Research Institute of Mount Sinai Hospital, a University of Toronto affiliated research centre established in 1985, is one of the world’s premier centres in biomedical research. Thirty-four principal investigators lead research in diabetes, cancer biology, epidemiology, stem cell research, women’s and infants’ health, neurobiology and systems biology. For more information on the Samuel Lunenfeld Research Institute, please visit www.lunenfeld.ca